Skip to content

Clinical trials

Small Cell Lung Carcinoma trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Country / region: Russia Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20051
20062
20071
20081
20111
20122
20131
20141
20161
20175
20183
20192
20202
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Active, not recruiting4
Terminated2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC4
AbbVie3
Hoffmann-La Roche3
AstraZeneca2
Bristol-Myers Squibb2
GlaxoSmithKline2
Pfizer2
Poniard Pharmaceuticals2
Sanofi2
Alaunos Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma29
Lung Neoplasms4
Recurrence3
Carcinoma, Non-Small-Cell Lung2
Neoplasm Metastasis2
Neoplasms2
Carcinoma1
Carcinoma, Hepatocellular1
Carcinoma, Transitional Cell1
Hypersensitivity1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.